COMMUNIQUÉS West-GlobeNewswire
-
CytoDyn to Host Investor Webcast
15/10/2026 -
TOMI Environmental Solutions Reports Independent Lab Results Showing SteraMist iHP Is Effective Against Listeria Biofilm, a Leading Cause of Food Recalls
15/10/2026 -
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
15/10/2026 -
Neumarker and Cortica Enter Strategic Partnership to Advance Precision Autism Care
15/10/2026 -
Chiesi Global Rare Diseases Supports Continued Generation of Real-World and Scientific Evidence in Epidermolysis Bullosa (EB), Including New Data Presented at 2026 PeDRA Annual Conference
15/10/2026 -
Chiesi Global Rare Diseases Supports Continued Generation of Real-World and Scientific Evidence in Epidermolysis Bullosa (EB), Including New Data Presented at 2026 PeDRA Annual Conference
15/10/2026 -
Canadians Overwhelmingly Support a Smoke-Free Generation Law, a New Poll Commissioned by National Lung Health Alliance Finds
15/10/2026 -
Selon un nouveau sondage commandé par la National Lung Health Alliance, les Canadiennes et les Canadiens appuient en forte majorité une loi pour une génération sans fumée (aussi appelée « génération sans tabac »)
15/10/2026 -
A Child's Light Partners with coeo Therapy to Expand Rapid-Response Youth Trauma Care into Montgomery County
15/10/2026 -
Ambio Life Sciences Partners with Athletes for Care to Provide Medically Supervised Ibogaine Programming and Support to Professional Athletes Living with Traumatic Brain Injury
15/10/2026 -
Revolution Medicines’ RASONQUE™ (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
15/10/2026 -
Nanox Selected as One of TIME’s Best Inventions of 2026 for its Nanox.ARC X
15/10/2026 -
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
15/10/2026 -
Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner
15/10/2026 -
NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives
15/10/2026 -
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study
15/10/2026 -
Alignment Health Expands Medicare Advantage Coverage to San Antonio for 2027
15/10/2026 -
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
15/10/2026 -
Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone
15/10/2026
Pages